Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Names HemaTone as China Distributor for Cancer Dx Products

NEW YORK (GenomeWeb) – Cancer molecular diagnostics firm Empire Genomics announced today that it has signed a distribution deal for its products in China with contract research organization HemaTone Beijing.

Growing demand in the region for cancer diagnostics was the impetus for the deal, which is expected to bring in more than $5 million in revenues for Empire over the five-year term of the agreement, the company said. HemaTone will distribute Empire's personalized diagnostic testing products in China, and will provide product training and marketing support to its clients.

Further financial terms were not disclosed.

"Finding a like-minded and experienced diagnostic partner such as HemaTone is crucial to our successful commercialization efforts in China," said Empire President and CEO Anthony Johnson in a statement. "Additional key requirements for us include deep Chinese regulatory knowledge and customer penetration. We chose HemaTone as our partner based on their strong track record of success with both of these attributes. We are excited to begin working with the HemaTone organization to bring the best in personalized medicine to the Chinese marketplace."

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.